Logo image of CNVI.CA

CONAVI MEDICAL CORP (CNVI.CA) Stock Fundamental Analysis

TSX-V:CNVI - TSX Venture Exchange - CA2059531020 - Common Stock - Currency: CAD

0.51  +0.03 (+6.25%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CNVI. CNVI was compared to 14 industry peers in the Health Care Equipment & Supplies industry. While CNVI seems to be doing ok healthwise, there are quite some concerns on its profitability. CNVI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CNVI had negative earnings in the past year.
CNVI had a negative operating cash flow in the past year.
In the past 5 years CNVI reported 4 times negative net income.
In the past 5 years CNVI reported 4 times negative operating cash flow.
CNVI.CA Yearly Net Income VS EBIT VS OCF VS FCFCNVI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M -60M

1.2 Ratios

Looking at the Return On Assets, with a value of -316.88%, CNVI is doing worse than 71.43% of the companies in the same industry.
CNVI has a Return On Equity (-722.25%) which is in line with its industry peers.
Industry RankSector Rank
ROA -316.88%
ROE -722.25%
ROIC N/A
ROA(3y)-183.23%
ROA(5y)-374.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CNVI.CA Yearly ROA, ROE, ROICCNVI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5K 10K

1.3 Margins

In the last couple of years the Operating Margin of CNVI has grown nicely.
CNVI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3Y34.2%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CNVI.CA Yearly Profit, Operating, Gross MarginsCNVI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100 -150

More info and screens

4

2. Health

2.1 Basic Checks

CNVI does not have a ROIC to compare to the WACC, probably because it is not profitable.
CNVI has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CNVI has been increased compared to 5 years ago.
Compared to 1 year ago, CNVI has an improved debt to assets ratio.
CNVI.CA Yearly Shares OutstandingCNVI.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
CNVI.CA Yearly Total Debt VS Total AssetsCNVI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

CNVI has an Altman-Z score of -119.17. This is a bad value and indicates that CNVI is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -119.17, CNVI is doing worse than 92.86% of the companies in the same industry.
CNVI has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.26, CNVI is in the better half of the industry, outperforming 64.29% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z -119.17
ROIC/WACCN/A
WACC7.73%
CNVI.CA Yearly LT Debt VS Equity VS FCFCNVI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M

2.3 Liquidity

A Current Ratio of 2.21 indicates that CNVI has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.21, CNVI is doing good in the industry, outperforming 78.57% of the companies in the same industry.
A Quick Ratio of 2.21 indicates that CNVI has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.21, CNVI is in the better half of the industry, outperforming 78.57% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.21
Quick Ratio 2.21
CNVI.CA Yearly Current Assets VS Current LiabilitesCNVI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

More info and screens

1

3. Growth

3.1 Past

CNVI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -2031.34%.
CNVI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -50.70%.
CNVI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.43% yearly.
EPS 1Y (TTM)-2031.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-894.37%
Revenue 1Y (TTM)-50.7%
Revenue growth 3Y6.43%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CNVI.CA Yearly Revenue VS EstimatesCNVI.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2023 5M 10M 15M 20M 25M
CNVI.CA Yearly EPS VS EstimatesCNVI.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 -1 -2 -3 -4 -5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CNVI. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CNVI.CA Price Earnings VS Forward Price EarningsCNVI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CNVI.CA Per share dataCNVI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CNVI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CONAVI MEDICAL CORP

TSX-V:CNVI (7/28/2025, 7:00:00 PM)

0.51

+0.03 (+6.25%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-27 2025-03-27
Earnings (Next)08-11 2025-08-11
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners0.38%
Ins Owner ChangeN/A
Market Cap39.14M
Analysts80
Price Target0.75 (47.06%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.5
P/FCF N/A
P/OCF N/A
P/B 19.93
P/tB 19.93
EV/EBITDA N/A
EPS(TTM)-1.13
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)-0.25
OCFYN/A
SpS0.11
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -316.88%
ROE -722.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-183.23%
ROA(5y)-374.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y34.2%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover1.94
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 19.42%
Cap/Sales 1.38%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.21
Quick Ratio 2.21
Altman-Z -119.17
F-Score1
WACC7.73%
ROIC/WACCN/A
Cap/Depr(3y)113.75%
Cap/Depr(5y)424.92%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2031.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-894.37%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-50.7%
Revenue growth 3Y6.43%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-186.15%
EBIT growth 3Y42.83%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y24.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y23.14%
OCF growth 3YN/A
OCF growth 5YN/A